The company PR'd a timeline for progress and has so far kept up with it. Start to worry if they start missing their ETAs. Quote: Upcoming Milestones Response to FDA questions: Q3 2013 Initiate HemaXellerate trial: Q4 2013 Complete HemaXellerate trial: Q4 2014-Q2 2015 In license Min technology: Q2 2013 File IND on Min technology: Q4 2013 Initiate clinical trial on Min technology: Q4 2013 Complete clinical trial on Min technology: Q4 2014-Q2 2015
FOLKS IT'S TIME TO BUY BMSN! BMSN = FUTURE MONEY ON THE TABLE
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.